# Evommune, Inc. (EVMN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Evommune, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/EVMN/mda/fy2025/): filed 2026-03-05; accession 0001193125-26-093932 (https://www.sec.gov/Archives/edgar/data/2044725/000119312526093932/evmn-20251231.htm); latest 10-K

Back to /company/EVMN/